Influence of Medication-Induced Preconditioning or Remote Ischemic Preconditioning on the Intrinsic Vascular Extracellular RNA/Ribonuclease System in Cardioprotection

Abstract

Background It has been demonstrated that remote ischemic preconditioning (RIPC) increases ribonuclease (RNase) levels and protects the heart by reducing extracellular ribonucleic acid (eRNA). As medication-induced preconditioning (MIPC) is also a powerful tool for cardioprotection, we examined the influence of both types of preconditioning on the eRNA/RNase system.

Methods In 17 male rats, RIPC (3 × 5 minute hind-leg ischemia) or MIPC (isoflurane and buprenorphine anesthesia) was performed. Five rats served as control and did not undergo preconditioning (non-MIPC). After preconditioning, eRNA levels and RNase activity were determined in plasma, and the hearts were mounted on a blood-perfused Langendorff ischemia/reperfusion apparatus. Hemodynamic, metabolic, and electron microscopic parameters were determined. Furthermore, MIPC with one anesthetic drug only (isoflurane, buprenorphine, or etomidate) was induced in another five rats. After 30 minutes, eRNA levels and RNase activity were determined and compared with an RIPC group (n = 5).

Results The plasma of RIPC-treated rats had higher RNase activity and lower eRNA levels than that of MIPC-treated rats. In addition, RIPC increased RNase activity more than MIPC with one drug alone. The RNase activity and eRNA levels in these MIPC groups differed considerably. Hemodynamic parameters of RIPC- and MIPC-treated hearts were better preserved after 90-minute ischemia than those of non-MIPC hearts. No obvious differences were noted between MIPC and RIPC regarding hemodynamics, metabolism, or structural parameters.

Conclusions Our results suggest that RIPC does not have any additional cardioprotective benefit in this experimental system. However, the influence of RIPC on the eRNA/RNase system was greater than that of MIPC.

Keywords

myocardial protection/cardioplegia - ischemia/reperfusion - organ preservation - anesthesia

Note

Presented at the 47th annual meeting of the DGTHG (Deutsche Gesellschaft für Thorax-, Herz- und Gefäßchirurgie), Leipzig, February 18, 2018.

• References

• 1 Hausenloy DJ, Candilio L, Evans R. , et al; ERICCA Trial Investigators. Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med 2015; 373 (15) 1408-1417
• 2 Meybohm P, Bein B, Brosteanu O. , et al; RIPHeart Study Collaborators. A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med 2015; 373 (15) 1397-1407
• 3 Thielmann M, Kottenberg E, Kleinbongard P. , et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet 2013; 382 (9892): 597-604
• 4 Zangrillo A, Musu M, Greco T. , et al. Additive effect on survival of anaesthetic cardiac protection and remote ischemic preconditioning in cardiac surgery: a Bayesian network meta-analysis of randomized trials. PLoS One 2015; 10 (07) e0134264
• 5 Heusch G, Rassaf T. Time to give up on cardioprotection? A critical appraisal of clinical studies on ischemic pre-, post-, and remote conditioning. Circ Res 2016; 119 (05) 676-695
• 6 Kottenberg E, Thielmann M, Bergmann L. , et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial. Acta Anaesthesiol Scand 2012; 56 (01) 30-38
• 7 Cabrera-Fuentes HA, Niemann B, Grieshaber P. , et al. RNase1 as a potential mediator of remote ischaemic preconditioning for cardioprotection. Eur J Cardiothorac Surg 2015; 48 (05) 732-737 , discussion 737
• 8 Cabrera-Fuentes HA, Ruiz-Meana M, Simsekyilmaz S. , et al. RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-α in cardiac ischaemia/reperfusion injury. Thromb Haemost 2014; 112 (06) 1110-1119
• 9 Stieger P, Daniel JM, Thölen C. , et al. Targeting of extracellular RNA reduces edema formation and infarct size and improves survival after myocardial infarction in mice. J Am Heart Assoc 2017; 6 (06) e004541
• 10 Simsekyilmaz S, Cabrera-Fuentes HA, Meiler S. , et al. Role of extracellular RNA in atherosclerotic plaque formation in mice. Circulation 2014; 129 (05) 598-606
• 11 Fischer S, Gerriets T, Wessels C. , et al. Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor. Blood 2007; 110 (07) 2457-2465
• 12 Kannemeier C, Shibamiya A, Nakazawa F. , et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A 2007; 104 (15) 6388-6393
• 13 Zernecke A, Preissner KT. Extracellular ribonucleic acids (RNA) enter the stage in cardiovascular disease. Circ Res 2016; 118 (03) 469-479
• 14 Böning A, Hagmüller S, Heep M, Rohrbach S, Niemann B, Mühlfeld C. Is warm or cold Calafiore blood cardioplegia better? Hemodynamic, metabolic, and electron microscopic differences. Thorac Cardiovasc Surg 2014; 62 (08) 683-689
• 15 Böning A, Rohrbach S, Kohlhepp L. , et al. Differences in ischemic damage between young and old hearts--Effects of blood cardioplegia. Exp Gerontol 2015; 67: 3-8
• 16 DiBona DR, Powell Jr WJ. Quantitative correlation between cell swelling and necrosis in myocardial ischemia in dogs. Circ Res 1980; 47 (05) 653-665
• 17 Mühlfeld C, Richter J. High-pressure freezing and freeze substitution of rat myocardium for immunogold labeling of connexin 43. Anat Rec A Discov Mol Cell Evol Biol 2006; 288 (10) 1059-1067
• 18 Schmiedl A, Schnabel PA, Mall G. , et al. The surface to volume ratio of mitochondria, a suitable parameter for evaluating mitochondrial swelling. Correlations during the course of myocardial global ischaemia. Virchows Arch A Pathol Anat Histopathol 1990; 416 (04) 305-315
• 19 Fischer S, Nishio M, Dadkhahi S. , et al. Expression and localisation of vascular ribonucleases in endothelial cells. Thromb Haemost 2011; 105 (02) 345-355
• 20 Zimmerman SB, Sandeen G. A sensitive assay for pancreatic ribonuclease. Anal Biochem 1965; 10: 444-449
• 21 Swyers T, Redford D, Larson DF. Volatile anesthetic-induced preconditioning. Perfusion 2014; 29 (01) 10-15
• 22 Headrick JP, See Hoe LE, Du Toit EF, Peart JN. Opioid receptors and cardioprotection - ‘opioidergic conditioning’ of the heart. Br J Pharmacol 2015; 172 (08) 2026-2050
• 23 Lucchinetti E, Bestmann L, Feng J. , et al. Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on-pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection?. Anesthesiology 2012; 116 (02) 296-310